NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/23/2024
Back to search
Official data from USPTO
NIPRO PHARMAPACKAGING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
05/23/2024
Trademark type
Combined
Nice classes
10, 21
Filing date
12/04/2015
Registration date
04/24/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2024
Last transaction
05/23/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/04/2016
First use in commerce
01/04/2016
Drawing code
3
Owner type
03
Owner location
Settsu, Osaka, JP
Examiner
BAKER, JORDAN A
Law office
N60
Current location
Historical data usage
Mark description
The mark consists of the words "NIPRO" in stylized font with "PHARMAPACKAGING" below in all capital letters. There is an infinity shaped symbol to the left of the words.
Holders and representatives
Holders
N. C. (pessoa física)
N. C. (pessoa física)
Representatives
Jerald E. Nagae, Reg. No. 29,418 CHRISTENSEN O'CONNOR JOHNSON KINDNESS
Technical classification
Nice Classes
Class 10Class 21
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical syringes sold empty in sterile and non-sterile condition
Class 21
Glass containers for holding and storing pharmaceutical and medical substancesampoules and vialsall products above sold emptyin sterile and non-sterile condition; Unworked or semi-worked glass; Industrial packaging containers of glass for medical and pharmaceutical substances
Publications
History of USPTO decisions and trademark events.
35 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/23/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/20/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/24/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/24/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/23/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/22/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/22/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/21/2018
IUAF
USE AMENDMENT FILED
03/06/2018
EISU
TEAS STATEMENT OF USE RECEIVED
03/06/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/02/2017
EX2G
SOU EXTENSION 2 GRANTED
08/31/2017
EXT2
SOU EXTENSION 2 FILED
08/31/2017
EEXT
SOU TEAS EXTENSION RECEIVED
08/31/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/14/2017
EX1G
SOU EXTENSION 1 GRANTED
02/10/2017
EXT1
SOU EXTENSION 1 FILED
02/10/2017
EEXT
SOU TEAS EXTENSION RECEIVED
02/10/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/20/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/26/2016
PUBO
PUBLISHED FOR OPPOSITION
07/26/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/16/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/15/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/14/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/14/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2016
GNRT
NON-FINAL ACTION E-MAILED
02/22/2016
CNRT
NON-FINAL ACTION WRITTEN
02/22/2016
DOCK
ASSIGNED TO EXAMINER
02/19/2016
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/10/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2015
NWAP
NEW APPLICATION ENTERED
12/08/2015
Continuous trademark protection
Get notified about every new filing that threatens NIPRO PHARMAPACKAGING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.